Medical device to relieve pain and extend the time to hip replacement for osteoarthritis of the hip patients. No FDA hurdle. Product launched.
Company develops and markets medical devices for the physical therapy (PT) market. First launched product is HipTrac, a Class I Device needing no further FDA approval and targeted at hip osteoarthritis (OA) patients. Hip OA is common and afflicts ca. 15-24 million people, 1/4 over 60. HipTrac relieves pain and delays surgery and is used by the patient at home as an adjunct to PT.